New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2013
12:36 EDTIPXL, SIG, JNS, AGN, AMJHigh option volume; IPXL SIG JNS AGN AMJ
News For IPXL;SIG;JNS;AGN;AMJ From The Last 14 Days
Check below for free stories on IPXL;SIG;JNS;AGN;AMJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
May 17, 2013
08:41 EDTIPXLImpax commenced shipment of authorized generic Zomig
Impax (IPXL) announced that its generics division, Global Pharmaceuticals, commenced shipment of authorized generic Zomig tablets, as part of an agreement with AstraZeneca (AZN). Zomig is indicated for the treatment of migraine headaches in adults. According to IMS Health data, U.S. sales of Zomig tablets and orally disintegrating tablets were approximately $196M in the 12 months ended April 2013.
May 15, 2013
06:06 EDTJNSJanus Capital downgraded to Underweight from Overweight at Barclays
Barclays downgraded Janus two notches to Underweight from Overweight citing valuation, lack of catalysts to move shares higher, and increased caution on the traditional asset manager group. Price target lowered to $8 from $9.
May 14, 2013
10:01 EDTSIGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:57 EDTSIGSignet Jewelers initiated with an Overweight at Stephens
Target $80.
07:18 EDTAGNBofA/Merrill to host a conference
2013 Health Care Conference is being held in Las Vegas on May 14-16.
May 13, 2013
07:49 EDTIPXLFDA decision on Opana a modest positive for Impax, says Leerink
Leerink views the FDA's denial of Endo's (ENDP) Citizen Petition as a modest positive for Impax (IPXL), which it notes is the sole holder of 180 day exclusivity on generic Opana. However, Leerink says upside for Impax will be limited as Actavis (ACT), Sandoz, and Teva (TEVA) have settlements to enter the market starting in June 2013 when Impax's 180-day generic exclusivity expires.
May 10, 2013
10:00 EDTAGNOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 3D Systems (DDD) initiated with a Buy at Janney Capital... Actavis (ACT) initiated with an Outperform at BMO Capital... Allergan (AGN) initiated with an Outperform at BMO Capital... Emeritus (ESC) initiated with an Outperform at Wells Fargo... Ensign Group (ENSG) initiated with a Market Perform at Wells Fargo... Forest Labs (FRX) initiated with an Underperform at BMO Capital... J2 Global (JCOM) initiated with an Outperform at Wedbush... Mylan (MYL) initiated with an Underperform at BMO Capital... Splunk (SPLK) initiated with a Market Perform at FBR Capital... Teva (TEVA) initiated with an Outperform at BMO Capital... Workday (WDAY) initiated with an Outperform at Oppenheimer... Nuance (NUAN) initiated with an Outperform at Wedbush... Demandware (DWRE) initiated with an Outperform at Wedbush... Synchronoss (SNCR) initiated with an Outperform at Wedbush... Trius Therapeutics (TSRX) initiated with a Buy at Guggenheim... Proto Labs (PRLB) initiated with a Buy at Janney Capital... Stratasys (SSYS) initiated with a Buy at Janney Capital.
May 9, 2013
16:34 EDTAGNAllergan initiated with an Outperform at BMO Capital
Subscribe for More Information
May 8, 2013
06:09 EDTAGNStocks with implied volatility below IV index mean; EBIX AGN
Subscribe for More Information
May 7, 2013
13:08 EDTAGNAllergan can still deliver double digit earnings growth, says Argus
Subscribe for More Information
05:57 EDTAGNStocks with implied volatility below IV index mean; IBM AGN
Subscribe for More Information
May 6, 2013
06:01 EDTAGNStocks with implied volatility below IV index mean; NFLX AGN
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.